Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Ben-Batalla, I., Cubas-Cordova, M., Udonta, F., Wroblewski, M., Waizenegger, J. S., Janning, M., Sawall, S., Gensch, V., Zhao, L., Martinez, I. Z., Riecken, K., Fehse, B., Pantel, K., Bokemeyer, C., & Loges, S. OncoTarget, 6(8):6341–6358, 2015.
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs [link]Paper  bibtex   
@article{ben-batalla_cyclooxygenase-2_2015,
	Author = {Ben-Batalla, Isabel and Cubas-Cordova, Miguel and Udonta, Florian and Wroblewski, Mark and Waizenegger, Jonas S. and Janning, Melanie and Sawall, Stefanie and Gensch, Victoria and Zhao, Lin and Martinez, Inigo Zubiavrre and Riecken, Kristoffer and Fehse, Boris and Pantel, Klaus and Bokemeyer, Carsten and Loges, Sonja},
	Journal = {OncoTarget},
	Number = {8},
	Pages = {6341--6358},
	Title = {Cyclooxygenase-2 blockade can improve efficacy of {VEGF}-targeting drugs},
	Url = {http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget},
	Volume = {6},
	Year = {2015},
	Bdsk-Url-1 = {http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget}}

Downloads: 0